Navigation Links
Building bridges between the clinic and the laboratory
Date:8/4/2008

Cambridge, UK, 04 August 2008 - Disease Models & Mechanisms (DMM) is the first journal to focus on translational research and the use of model organisms to advance human health. Published by the Company of Biologists, DMM is a highly anticipated biomedical research journal which officially launched its inaugural issue both in print and online today at http://DMM.biologists.org.

DMM focuses on human disease and the research necessary to develop treatments for illness. The field of translational medicine where basic science research is "translated" into treatments and cures for disease has been growing exponentially, particularly given the recent advances in genomics and life sciences, and shifts in global research funding. DMM aims to fill a niche in translational research by publishing articles about human disease and the model organisms used in biomedical research.

The special inaugural issue features editorial commentary, review articles, and research highlights on topics ranging from cancer detection, to understanding human diseases using flies or worms and the future impact of mouse genetics on humankind. Future issues will include primary research articles, and DMM continues to invite authors to submit articles which focus on human disease. Interviews and Podcasts focusing on areas of special interest will become regular features.

DMM's founders believe that the journal will provide a community forum for clinicians and scientists to discuss their findings and observations. DMM's Editor-in-Chief, Vivian Siegel, invites students, fellows, policymakers, clinicians, and scientists to "use the journal and its website to share resources and discoveries".

In addition to its publishing goals, the journal is committed to assisting early-career scientists by offering travelling fellowships to graduate students and postdoctoral fellows. Awards of up to US$5000/₤2500 are offered to facilitate collaborative visits to other laboratories worldwide. Fellowship application forms can be downloaded from the DMM website.

Disease Models & Mechanisms will publish 5 issues in 2008. Issue 1 is a special inaugural issue; issues 2/3 and 4/5 will be combined double issues. From 2009, DMM will be published every month (12 issues/year). Authors benefit from a free trial period for access to DMM, which will be available until at least spring 2009. DMM is a new addition to the international journals published by the Company of Biologists, a not-for-profit publisher based in Cambridge, UK.


'/>"/>

Contact: Donna Perry
donna@biologists.com
44-122-342-6164
The Company of Biologists
Source:Eurekalert

Related biology news :

1. 1/3 of reef-building corals face extinction
2. NJIT architect professor advocates best-building practices for high wind regions
3. Manchester clears first hurdle in €170 million biobank building boom
4. Building on pyramids of trash
5. UCI awarded $27.2 million for new stem cell building
6. Scientists make chemical cousin of DNA for use as new nanotechnology building block
7. In Todays Economy, You Can Strengthen Your Company by Building Your Brand
8. International workshop to address capacity building for rainforest leaders
9. Building the future -- 21st century nano tools to repair the nervous system
10. Building disease-beating wheat
11. Building blocks of life formed on Mars
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/21/2016)... , June 21, 2016 NuData Security announced ... new role of principal product architect and that ... director of customer development. Both will report directly ... officer. The moves reflect NuData,s strategic growth in ... to high customer demand and customer focus values. ...
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the ... the Dow Jones Industrial Average edged 0.27% lower to finish ... 0.17%. Stock-Callers.com has initiated coverage on the following equities: Infinity ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... ). Learn more about these stocks by accessing their free ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... Cell Applications, Inc. and StemoniX announced ... up to one billion human induced pluripotent stem ... These high-quality, consistent stem cells enable researchers to ... more time doing meaningful, relevant research. This achievement ... process that produces affordable, reliable HiPSC for life ...
Breaking Biology Technology: